Alberto Kornblihtt was raised in Buenos Aires, Argentina. His parents both taught (mathematics and geography), and his siblings pursued careers in science and teaching, attesting to the passion for knowledge and education instilled by their parents. Kornblihtt always knew that he would be a scientist, and he settled on biology in high school after learning about DNA, RNA, proteins, and the genetic code from the plant taxonomist Rosa Guaglianone. High school also marked his introduction to Joachim Hämmerling's 1943 experiments, which show that the morphology of the single-cell alga Acetabularia is controlled by the nucleus. His interest in the regulation of gene expression and the mechanisms eliciting RNA and protein diversity led him to pursue a PhD at the Campomar Foundation, Argentina, under the supervision of Héctor Torres, a trainee of the Argentine biochemist and Nobel laureate Luis Leloir, who was still at the time an active scientist at the institute. During his postdoc with Francisco "Tito" Baralle at the Sir William Dunn School of Pathology in Oxford, England, Kornblihtt cloned the human fi bronectin gene and found that it could generate up to 20 polypeptides through alternative pre-mRNA splicing. We contacted him to learn more about his passion for the mechanisms of RNA splicing, his career, and his research.
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What are you currently working on?
Epigenetic changes occurring in internal regions of genes affect alternative splicing (AS) decisions, through both the modulation of RNA polymerase II (RNA PII) elongation rates and the recruitment of splicing factors to the nascent pre-mRNA. For example, we found that changes in nerve cell activity and neuron differentiation that relax or tighten chromatin structure promote changes in transcriptional elongation, which in turn affect AS of genes essential for neuronal function. Furthermore, we studied the enzyme responsible for H3K9 dimethylation in mammalian euchromatin, named G9a (1). We found that G9a is required for differentiation of mouse neuronal cells and that inclusion of one of its alternative exons promotes G9a nuclear localization and neuron differentiation.
Another aspect of our research relates to chromatin and the nuclear effects of the small RNA machinery. The prevalent view is that, in mammalian cells, argonaute proteins only function in the cytoplasm through a mechanism known as posttranscriptional gene silencing. This view neglects the existence of the nuclear mechanism known as transcriptional gene silencing in these cells. However, we showed that siRNAs play nuclear roles in the control of alternative pre-mRNA splicing (2) . siRNAs targeting intronic sequences close to an alternative exon regulate the splicing of that exon. The effect depends on argonaute-1 (AGO1) and is mediated by the "writing" heterochromatin marks (H3K9me2 and H3K27me3) at the target site that create roadblocks for RNA PII elongation. Surprisingly, AGO1 binds to active transcriptional enhancers (2) . Currently, we are investigating how AGO1 interacts with transcription factors and how these complexes activate transcription of genes controlled by the targeted enhancers.
Lastly, we study DNA damage and AS in human skin cells. UV irradiation affects cotranscriptional AS through the hyperphosphorylation of the RNA PII carboxy-terminal domain and inhibition of transcriptional elongation (3) . We now demonstrate that UV-induced DNA damage is not only necessary but suffi cient to trigger the AS response and that photolyase-mediated removal of cyclobutane pyrimidine dimers (CPDs) abrogates the global response to UV. In skin cells, RNA PII is the target, but not a sensor, of the signaling cascade initiated by CPDs, and single-stranded DNA stretches generating during lesion (CPD) repair activate the protein kinase ATR that mediates the UV-induced RNA PII hyperphosphorylation. Our results link DNA damage repair to the control of gene expression both at the transcriptional and RNA splicing levels.
You also study AS in plants, correct?
Yes, we showed that light/dark conditions affect AS of a subset of Arabidopsis genes encoding proteins involved in RNA processing (4). The effect requires functional chloroplasts and is observed in roots when the communication with photosynthetic tissues is not interrupted, suggesting a signaling molecule is involved. Using photosynthetic inhibitors with different mechanisms of action, we showed that the reduced pool of plastoquinones initiates chloroplast retrograde signaling that regulates nuclear AS. Surprisingly, we found, but have not yet published, that the effect of light on AS involves changes in transcription elongation. Indeed, in a plant defective in the elongation factor TFI IS, the light/dark effect on AS is completely abolished.
What is up next for you?
Spinal muscular atrophy is a severe genetic disorder of motor neurons that is caused by loss-of-function mutations in the survival motor neuron 1 (SMN1) gene. Humans have a paralog of SMN1, named SMN2. Because of a variation in a single nucleotide, SMN2 exon 7 (E7) is poorly included in the mature mRNA, so that ∼10-20% of SMN2 transcripts encode the fully functional protein, while the remaining 80-90% encode a truncated, nonfunctional protein. Therefore, in the absence of SMN1, SMN2 cannot compensate for SMN protein defi ciency. We
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wish to identify drugs that, by affecting RNA PII elongation or chromatin structure, may be used in combination with allele-specifi c oligonucleotide-driven therapies to improve the inclusion levels of SMN2 E7 in the mature mRNA. 
What has been the biggest challenge in your career so far?
Overcoming the terrible anguish that invades you when a paper or application is rejected.
Learn that it's your work that is being criticized, not you, your capacities, or your integrity.
What has been the biggest accomplishment in your career so far?
In 1995, I suggested to a new graduate student in the laboratory to explore if changing the RNA PII promoter of a gene with the RNA PII promoter of another gene would affect the patterns of AS of the produced transcript. She showed that changing promoters caused a 10-fold increase in the inclusion levels of an alternative cassette into the mature mRNA (5). This was the fi rst evidence that transcription and splicing are not independent events, but that the outcome of splicing depends on the parameters of transcription. This coupling involves two nonexclusive working models: AS is affected by the recruitment of splicing factors to the transcription apparatus (recruitment coupling) or by the speed of RNA PII elongation (kinetic coupling). We showed how changes in RNA PII elongation promote inclusion (6) or skipping (7) of alternative exons.
What has been your biggest accomplishment outside of the laboratory?
Since 1985, I have taught an introductory course on molecular and cell biology at the University of Buenos Aires to ∼400 undergraduate students every year. I feel proud that many generations of now successful scientists, here and abroad, were inspired by this course. Further outside of the laboratory, I feel proud of my two sons-the younger one is a photographer and the older one is a historian-and of the always renewed relationship with my wife, who is a psychoanalyst.
What are your hobbies?
I am a cinephile. I keep a record of all the movies I've seen in my life (∼2,000 so far). I also love cooking, creating conceptual art, etymology, playing Scrabble, and listening to classical music. I love reading movie scripts, texts in Latin, poetry, and novels, if possible in their original languages.
What would you be if you were not a scientist?
Within science, I would have loved to be a geologist or to study linguistics and the origin of languages. Outside of science, I love architecture.
Any tips for a successful research career?
Hard work. Honesty. Respect for others. Do not read too much scientifi c literature; it limits your creativity. Explore your own ideas and only then, before doing the experiments, check if someone else has already published something similar. Team work. Do not act as the "boss" of your graduate students and postdocs. They are not working for you, they are working for themselves. They are not your employees. You are their advisor, their mentor. Be consistent along time with the subject of your research; do not switch from subject to subject. Publish few but sound papers in which your leadership and contribution are clear.
